The SLC2A1 gene is associated with a condition known as paroxysmal exercise-induced dyskinesia (PED), which can sometimes co-occur with epilepsy and/or hemolytic anemia. This condition is characterized by sudden, involuntary movements that are often triggered by prolonged exercise, stress, or fatigue. In some cases, individuals may also experience seizures or an abnormal breakdown of red blood cells, leading to hemolytic anemia.
The genetic test for this condition focuses on identifying mutations in the SLC2A1 gene, which provides instructions for making a protein that transports glucose across the blood-brain barrier. Glucose is the brain's primary energy source, and disruptions in its transport can lead to neurological symptoms.
DNA Labs UAE offers a comprehensive genetic test for diagnosing mutations in the SLC2A1 gene associated with paroxysmal exercise-induced dyskinesia, epilepsy, and/or hemolytic anemia. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the SLC2A1 gene. This test is crucial for individuals exhibiting symptoms related to these conditions, as it can provide a definitive diagnosis, inform treatment strategies, and guide family planning decisions.
The PNKD Gene Paroxysmal Nonkinesigenic Dyskinesia Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the PNKD gene, which are linked to Paroxysmal Nonkinesigenic Dyskinesia (PNKD). This condition is characterized by sudden, involuntary movements that can include spasms, twisting motions, or flailing limbs, which occur without a specific trigger like sudden movement. Unlike other forms of dyskinesia, episodes are not initiated by kinesigenic activity and can last for minutes to hours.
The test is crucial for individuals showing symptoms of PNKD, as a positive identification of mutations in the PNKD gene can confirm the diagnosis, allowing for a tailored management plan. Early diagnosis can significantly improve the quality of life for individuals with PNKD by providing insights into potential triggers, effective treatments, and lifestyle adjustments.
At a cost of 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic alterations in the PNKD gene. Results from this test can provide definitive answers for affected individuals and their families, guiding decisions about management and care.
The ARX Gene Partington Syndrome Genetic Test is a specialized diagnostic procedure conducted at DNA Labs UAE, aimed at identifying mutations in the ARX gene, which are known to cause Partington syndrome. This rare genetic disorder is characterized by intellectual disability, dystonic hand movements, and sometimes epilepsy. The test involves analyzing the patient's DNA to detect abnormalities in the ARX gene that may lead to the development of this condition.
The cost of the ARX Gene Partington Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is crucial for families seeking a definitive diagnosis of Partington syndrome, enabling them to understand the genetic basis of the condition and to explore potential treatment options and management strategies. By identifying the specific mutation, healthcare providers can offer personalized care and support to affected individuals and their families.
The PLP1 gene Pelizaeus-Merzbacher Disease (PMD) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PLP1 gene, which are responsible for causing Pelizaeus-Merzbacher Disease. PMD is a rare, genetic, central nervous system disorder characterized by a range of neurological symptoms, including motor abilities impairment, cognitive development issues, and coordination problems. The test is crucial for early diagnosis, which can aid in managing symptoms and improving the quality of life for affected individuals. The cost of the test is 4400 AED, making it an accessible option for those seeking comprehensive genetic analysis in the UAE. This test is particularly valuable for families with a history of PMD, offering them crucial information for family planning and management of the condition.
The SLC16A2 gene Pelizaeus-Merzbacher Disease (PMD) genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SLC16A2 gene, which are linked to the development of Pelizaeus-Merzbacher Disease. PMD is a rare, genetic neurological disorder characterized by a progressive decline in motor abilities, coordination, and cognitive functions, resulting from the improper formation of myelin in the central nervous system. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations associated with the condition. With a cost of 4400 AED, this test provides crucial information for the accurate diagnosis and management of Pelizaeus-Merzbacher Disease, enabling targeted treatment plans and genetic counseling for affected families.
The SOX10 Gene Peripheral Demyelinating Neuropathy, Waardenburg Syndrome, and Hirschsprung Disease Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the SOX10 gene. These mutations are known to be associated with a range of conditions, including peripheral demyelinating neuropathy, Waardenburg Syndrome, and Hirschsprung Disease. The test is crucial for individuals who exhibit symptoms related to these conditions or have a family history, as it aids in confirming the diagnosis, understanding the risk of passing the genetic mutation to offspring, and making informed decisions about management and treatment options. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the SOX10 gene and provide reliable results.
The ARFGEF2 Gene Periventricular Heterotopia with Microcephaly Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the ARFGEF2 gene. These mutations are associated with the development of Periventricular Heterotopia (PH) accompanied by microcephaly, a rare genetic disorder. PH is characterized by the presence of nodules of neurons in inappropriate locations in the brain due to their failure to migrate to the correct positions during development. This condition can lead to a range of neurological issues, including seizures, developmental delay, and difficulties with coordination and balance. Microcephaly, on the other hand, is a condition where a baby's head is significantly smaller than expected, often due to abnormal brain development.
The test, which costs 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the ARFGEF2 gene that are known to cause this complex condition. The results from this genetic testing can provide crucial information for the diagnosis, management, and understanding of the patient's condition. It can also offer valuable insights for family planning and genetic counseling for families affected by Periventricular Heterotopia with microcephaly. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable testing results.
The PEX11B Gene Peroxisome Biogenesis Disorder 14B Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the PEX11B gene, which are linked to Peroxisome Biogenesis Disorder 14B (PBD14B). This rare genetic condition affects the body's ability to properly form and function peroxisomes, essential cellular components involved in various critical biochemical pathways, including lipid metabolism and the detoxification of harmful substances.
PBD14B manifests with a spectrum of clinical features, ranging from severe neurological impairments to more subtle physiological anomalies, depending on the nature and extent of the genetic mutation. Early and accurate diagnosis through the PEX11B gene test can facilitate timely intervention and management strategies, potentially improving the quality of life for affected individuals.
The test is conducted with a sample of the patient's DNA, extracted from a blood sample or cheek swab, and analyzed using advanced genetic sequencing techniques to detect mutations in the PEX11B gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic alterations associated with this disorder.
DNA Labs UAE is at the forefront of genetic testing, offering this critical diagnostic tool as part of its comprehensive suite of genetic services. By providing this test, DNA Labs UAE supports the early detection and management of Peroxisome Biogenesis Disorder 14B, contributing to the broader effort to combat rare genetic diseases.
The "PEX3 Gene Peroxisome Biogenesis Disorder Type 10A Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the PEX3 gene. These mutations are associated with Peroxisome Biogenesis Disorder Type 10A (PBD10A), a rare genetic condition that affects the body's ability to produce peroxisomes. Peroxisomes are essential for various cellular functions, including lipid metabolism and the detoxification of harmful substances.
This genetic test is critical for early detection and management of PBD10A, enabling healthcare providers to develop a tailored treatment plan for affected individuals. The test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the PEX3 gene.
Offered at a cost of 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The test's accuracy and the lab's reputation make it a valuable resource for families with a history of PBD10A or related symptoms, providing them with crucial information about their genetic health and guiding future medical decisions.
The PEX1 Gene Peroxisome Biogenesis Disorder Type 1B Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the PEX1 gene, which are linked to Peroxisome Biogenesis Disorder Type 1B (PBD-ZSD). This condition is part of a spectrum of disorders that affect the normal function and formation of peroxisomes, cellular structures essential for various metabolic processes, including the breakdown of fatty acids and the detoxification of hydrogen peroxide.
Mutations in the PEX1 gene disrupt these critical functions, leading to a wide range of symptoms such as developmental delays, vision and hearing impairments, liver dysfunction, and abnormalities in bone formation. Early and accurate diagnosis through this genetic test can be crucial for managing symptoms, planning treatment strategies, and providing genetic counseling for affected families.
The test is conducted through a blood sample or cheek swab, utilizing advanced genetic sequencing techniques to identify mutations in the PEX1 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized expertise required to interpret the results accurately. By opting for this test at DNA Labs UAE, patients and their families gain access to crucial information that can guide medical and lifestyle decisions, enhancing the quality of life for those affected by Peroxisome Biogenesis Disorder Type 1B.
